I

Integer Holdings Corp
NYSE:ITGR

Watchlist Manager
Integer Holdings Corp
NYSE:ITGR
Watchlist
Price: 135.705 USD 0.71% Market Closed
Market Cap: 4.6B USD
Have any thoughts about
Integer Holdings Corp?
Write Note

Integer Holdings Corp
PP&E Net

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Integer Holdings Corp
PP&E Net Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company PP&E Net CAGR 3Y CAGR 5Y CAGR 10Y
I
Integer Holdings Corp
NYSE:ITGR
PP&E Net
$568.1m
CAGR 3-Years
24%
CAGR 5-Years
16%
CAGR 10-Years
15%
Becton Dickinson and Co
NYSE:BDX
PP&E Net
$6.8B
CAGR 3-Years
2%
CAGR 5-Years
4%
CAGR 10-Years
7%
Boston Scientific Corp
NYSE:BSX
PP&E Net
$3.5B
CAGR 3-Years
11%
CAGR 5-Years
12%
CAGR 10-Years
9%
Stryker Corp
NYSE:SYK
PP&E Net
$3.9B
CAGR 3-Years
8%
CAGR 5-Years
7%
CAGR 10-Years
14%
Abbott Laboratories
NYSE:ABT
PP&E Net
$10.6B
CAGR 3-Years
6%
CAGR 5-Years
4%
CAGR 10-Years
6%
Intuitive Surgical Inc
NASDAQ:ISRG
PP&E Net
$4.4B
CAGR 3-Years
37%
CAGR 5-Years
30%
CAGR 10-Years
29%
No Stocks Found

Integer Holdings Corp
Glance View

Market Cap
4.6B USD
Industry
Health Care

Integer Holdings Corporation, a prominent player in the medical device industry, has carved a significant niche by aligning innovation with robust manufacturing capabilities. Founded as a collaborative effort between technical ingenuity and healthcare innovation, Integer primarily engages in the design and production of medical devices and components that are instrumental for the med-tech sector. It serves a diverse clientele that ranges from large healthcare conglomerates to emerging med-tech companies. The company operates through two main segments: Medical and Non-Medical. In the Medical division, Integer excels by providing critical components used in cardiac rhythm management, neuromodulation, and vascular access. It thrives on the premise that precision in manufacturing and innovation are key to producing reliable and effective medical solutions, ensuring that they meet stringent regulatory standards. What truly propels Integer’s financial engine is its commitment to operational excellence and strategic partnerships. By integrating vertically across its production processes, Integer achieves cost efficiencies that allow it to offer competitive pricing without sacrificing quality. Moreover, the company extends its influence through strategic partnerships with prominent healthcare providers, thereby securing long-term contracts and steady revenue streams. This model is supplemented by its Non-Medical segment, where Integer provides high-reliability components for energy, military, and environmental applications. These ventures not only diversify its revenue portfolio but also bolster its resilience against market volatility. Integer’s growth narrative is underscored by a relentless focus on research and development, which facilitates continuous product enhancement and keeps it at the forefront of technological advancement in the medical device industry. Through these strategies, Integer Holdings Corporation not only sustains its market position but also expands its role as a critical enabler in the global healthcare landscape.

ITGR Intrinsic Value
133.271 USD
Overvaluation 2%
Intrinsic Value
Price
I

See Also

What is Integer Holdings Corp's PP&E Net?
PP&E Net
568.1m USD

Based on the financial report for Sep 27, 2024, Integer Holdings Corp's PP&E Net amounts to 568.1m USD.

What is Integer Holdings Corp's PP&E Net growth rate?
PP&E Net CAGR 10Y
15%

Over the last year, the PP&E Net growth was 29%. The average annual PP&E Net growth rates for Integer Holdings Corp have been 24% over the past three years , 16% over the past five years , and 15% over the past ten years .

Back to Top